FTSE 100 LIVE: Asian equities fall as vaccine trials halt and US aid package talks sour

We will use your email address only for sending you newsletters. Please see our Privacy Notice for details of your data protection rights.

Johnson & Johnson JNJ.N said it was pausing a coronavirus vaccine trial due to a study participant’s unexplained illness on Tuesday. Eli Lilly and Co LLY.N later said it too had paused the clinical trial of its COVID-19 antibody treatment. The treatment was halted due to a safety concern, leading the US equity market to deepen losses. J&J shares lost 2.3 percent, while Eli Lilly closed down nearly 3 percent.

This comes as hopes for the passage of a new coronavirus relief package faded as US House Speaker Nancy Pelosi rejected a $1.8 trillion relief proposal from the White House.

“U.S. stimulus talks are still going nowhere dimming the prospect of a new round of support this side of the election,” said Sydney-based NAB strategist Rodrigo Catril.

“So, for now it is hard to see a deal being agreed before Nov. 3, the market is still travelling with the notion that a new round of stimulus is coming, but at this stage this looks more likely after the election.”

MSCI’s broadest index of Asia-Pacific shares outside of Japan .MIAPJ0000PUS fell 0.2 percent. Japan’s Nikkei .N225 dipped 0.2 percent while Australia’s benchmark index .AXJO was off a touch and South Korea .KS11 stumbled 0.7 percent.



Source: Read Full Article